Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics Study of Posaconazole in Haematology Patients Receiving Standard of Care Treatment With Oral Posaconazole Prophylaxis for Invasive Fungal Infection

NCT03717623 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.

NCT NCT03717623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03717623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics Study of Posaconazole in Haematology Patients Receiving Standard of Care Treatment With Oral Posaconazole Prophylaxis for Invasive Fungal Infection
Lead sponsor
Melbourne Health
Phase
Phase 4
Overall status
Recruiting
Start date
August 1, 2019
Completion date
December 30, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fungal infection, invasive aspergillosis, invasive candidiases, invasive mycosis, pharmacokinetics, posaconazole, prophylaxis